In their CRISPR-mediated mutagenesis experiments, Wang et al. performed mutant p53 removal not only in cell lines, but also in human colon-cancer-derived organoids, analyzed in culture or as xenograft tumors [13]. This evidence concerns the gene TP53 and cancer.